Health

The case of Lucy Letby, a British nurse convicted of murdering multiple infants, has stirred a media storm and raised significant questions regarding the criminal justice system’s handling of medical evidence. Letby, 34, is currently serving a life sentence without the possibility of parole after she was found guilty of killing seven newborns and attempting
0 Comments
As the nation navigates the complexities of healthcare in 2023, troubling health trends are becoming evident. The CDC has noted a resurgence in flu and COVID-19 cases, presenting a dual threat that the public must confront. Alarmingly, a recent survey reveals that around 8% of U.S. adults may be grappling with long COVID, illustrating the
0 Comments
In today’s consumer-driven world, awareness of the substances used in everyday products is crucial for public health. The presence of per- and polyfluoroalkyl substances (PFAS), commonly found in household items like dental floss, has raised alarms among health professionals. Laurel Schaider, a senior scientist at the Silent Spring Institute, emphasizes the alarming fact that consumers
0 Comments
Recent research has illuminated the significant connection between our dietary choices and the risk of cognitive decline, particularly in the context of dementia. Notably, diets high in inflammatory foods have been associated with increased risks of all-cause dementia and Alzheimer’s dementia among older adults. This correlation was meticulously explored in a longitudinal study conducted with
0 Comments
Obeticholic acid, sold under the brand name Ocaliva, has been a focal point of treatment discussion for patients with Primary Biliary Cholangitis (PBC), a chronic liver disease that primarily afflicts women. This disease is characterized by the gradual destruction of bile ducts, which leads to inflammation, bile accumulation, and ultimately liver damage. While obeticholic acid
0 Comments
Chronic lymphocytic leukemia (CLL) represents a challenging paradigm in oncology, marked by complex therapeutic needs, especially in cases of relapse following standard treatments. New data emerging from a clinical trial shed light on Pirtobrutinib (also known as Jaypirca), a non-covalent Bruton’s tyrosine kinase (BTK) inhibitor, demonstrating its potential to delay disease progression in patients who
0 Comments
Primary biliary cholangitis (PBC) poses a significant challenge to hepatologists and patients alike. The landmark approval of ursodeoxycholic acid (UDCA) in 1997 was heralded as a breakthrough moment in the treatment of PBC, notably reducing the necessity for liver transplants and the risk of mortality. Nevertheless, the journey toward more comprehensive management strategies for PBC
0 Comments
Mirikizumab, known commercially as Omvoh, has recently garnered attention for its effectiveness in treating patients suffering from moderately-to-severely active Crohn’s disease, particularly those who have not responded to conventional therapies. A pivotal phase III randomized controlled trial showcased its potential by demonstrating significantly improved patient outcomes compared to placebo. This article delves into the study’s
0 Comments